2008
DOI: 10.1016/j.antiviral.2008.01.153
|View full text |Cite
|
Sign up to set email alerts
|

Genotypic detection of acyclovir-resistant HSV-1: Characterization of 67 ACV-sensitive and 14 ACV-resistant viruses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
58
0
4

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
4
1

Relationship

1
8

Authors

Journals

citations
Cited by 85 publications
(64 citation statements)
references
References 58 publications
2
58
0
4
Order By: Relevance
“…In addition, HSV infections resistant to nucleoside analogues are recognized as a clinical problem among immunocompromised patients (5). The prevalence of resistance is reported to be about 5% among these patients but can reach up to 14 to 30% among patients with allogeneic bone marrow transplants (6). Therefore, there is a need for effective alternatives to nucleoside analogue inhibitors, to provide more-efficient therapy (even after delayed onset) and to counteract resistance.…”
mentioning
confidence: 99%
“…In addition, HSV infections resistant to nucleoside analogues are recognized as a clinical problem among immunocompromised patients (5). The prevalence of resistance is reported to be about 5% among these patients but can reach up to 14 to 30% among patients with allogeneic bone marrow transplants (6). Therefore, there is a need for effective alternatives to nucleoside analogue inhibitors, to provide more-efficient therapy (even after delayed onset) and to counteract resistance.…”
mentioning
confidence: 99%
“…The TaqMan HSV quantitative real-time PCR assay integrating PCR inhibitor detection was performed using an iCycler IQ (Bio-Rad, Marnesla-Coquette, France) as described previously (6). The oligonucleotide primers used for amplification were constructed to detect the HSV-1 and HSV-2 glycoprotein B gene.…”
Section: Methodsmentioning
confidence: 99%
“…Mutations in the viral TK gene are associated with either polymorphism or drug resistance. The vast majority of mutations unrelated to acyclovir resistance are located outside TK conserved sites (10,19). Table 1 summarizes the HSV-1 UL23 sequencing data for the viral isolates from throat (H723) and skin (H724) lesions that showed differences from published sequences from both human herpesvirus 1 (HHV-1) strain 17 (17) and the HHV-1 strain KOS mutant KG111 (14).…”
Section: Case Reportmentioning
confidence: 99%
“…Based on the published sequence of HHV-1 strain 17 and KOS, the eight UL23 point mutations of our proven acyclovir-sensitive clinical strains are known to be associated with UL23 polymorphism: 23, 36, 240, 251, 267, 268, 286, and 376 (8,10,20). Furthermore, we were able to describe an additional six UL23 point mutations (34, 171, 232, 241, 305, and 351), which are not known to be associated with acyclovir resistance.…”
Section: Vol 46 2008 Case Reports 3163mentioning
confidence: 99%